T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1

Human Parainfluenza Virus-3 (HPIV3) causes severe respiratory illness in immunocompromised patients and lacks approved anti-viral therapies. A phase I study of adoptively transferred virus-specific T-cells (VSTs) targeting HPIV3 following bone marrow transplantation is underway (NCT03180216). We sou...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Katherine M., Horn, Sarah E., Grant, Melanie L., Lang, Haili, Sani, Gelina, Jensen-Wachspress, Mariah A., Kankate, Vaishnavi V., Datar, Anushree, Lazarski, Christopher A., Bollard, Catherine M., Keller, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573487/
https://www.ncbi.nlm.nih.gov/pubmed/33123159
http://dx.doi.org/10.3389/fimmu.2020.575977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573487/
https://www.ncbi.nlm.nih.gov/pubmed/33123159
http://dx.doi.org/10.3389/fimmu.2020.575977

Ejemplares similares